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Several novel nAChR subtype-selective α-conotoxins have recently been discovered, including α-CTX PIA and α-CTX BuIA Dowell et al., 2003) . α-CTX PIA has been used in the characterization of nAChRs that regulate [
3 H]DA release from striatal synaptosomes and confirmed a role for α6-containing subtypes . α-CTX BuIA can kinetically distinguish between β2 and β4-containing nAChRs . In the present study, we have used these toxins in combination with subunit null-mutant mice to characterize murine nAChRs that modulate [ Ci/mmol) (Perkin-Elmer, Boston, MA), Ecolume scintillation cocktail (MP, Costa Mesa, CA). α-Conotoxins were synthesized as previously described Cartier et al., 1996; McIntosh et al., 2004) .
MATERIALS AND METHODS

Materials
Tissue Preparation. Adult male Sprague-Dawley rats (Simonsen Laboratories, Gilroy, CA) were kept two per cage on a 12:12 hr light/dark cycle, with food and water available ad libitum. Male and female Sprague-Dawely rat pups (2-3 weeks old) were This article has not been copyedited and formatted. The final version may differ from this version.
Molecular Pharmacology Fast Forward. Published on May 30, 2006 as DOI: 10.1124 at ASPET Journals on July 6, 2017 molpharm.aspetjournals.org Downloaded from kept in the cage with the dam and both sexes were used for the experiments. C57Bl/6J
wildtype and null mutant mice that were bred onto C57Bl/6J background were provided by The Institute for Behavioral Genetics (University of Colorado, Boulder, CO) and used by permission from Dr. Arthur Beaudet (Baylor College of Medicine, Baylor, TX). The breeding triads (2 females, 1 male) were kept in the same cage and allowed to mate. Only the first generation pups for each genotype were used for the experiments. For each experiment, hippocampi from 2 adult male rats between 60 and 90 days old, 6 postnatal rats between 14-21 days old, or 2-3 adult male mice or 4-6 mice pups (males and females) between 14-20 days old were used. The animals were decapitated and brains quickly removed. This procedure was approved by the Institutional Animal Care and Use
Committee and is consistent with Federal guidelines. Synaptosomes were prepared as described by . Briefly, the hippocampus was quickly dissected on ice and placed in ice-cold 0.32 M sucrose buffer, pH 7.4-7.5. The dissected hippocampus was homogenized by 14 gentle up and down strokes, followed by centrifugation at 1000g for 10 min at 4 o C. The supernatant was centrifuged at 12,000g
for 20 min at 4 o C. The resulting P2 pellet was resuspended in 2 ml of Krebs-HEPES buffer (superfusion buffer) with composition (in mM): NaCl 128, KCl 2. centrifuged at 3500 rpm for 5 min in order to get rid of excess radiolabeled NE. The pellet was re-suspended in 4 ml of superfusion buffer and 1 ml was transferred into each of four conical tubes containing 3 ml of superfusion buffer and subsequently loaded into the superfusion chambers containing 13 mm diameter A/E glass fiber filters (Gelman Sciences, Ann Arbor, MI). One tube of the final synaptosomal preparation (4 ml total volume) contained enough synaptosomes for six chambers of the superfusion apparatus.
Superfusion. The superfusion system had 12 identical channels and was set up as described in Kulak et al. (1997) , except the peristaltic pumps were switched to Brandel pumps. Once synaptosomes were loaded into the superfusion apparatus, they were washed for 20 min with either superfusion buffer alone or buffer plus varying concentrations of the toxins, at a rate of 0.5 ml/min. For studies where the reversibility of α-CTX BuIA or α-CTX AuIB was examined, syaptosomes were first perfused with buffer containing toxin for 20 min and subsequently perfused for an additional 10 or 20 min with toxin-free buffer. Following the wash period, 2-min fractions were collected in 6 ml polypropylene vials containing 4 ml of Ecolume scintillation cocktail. At the end of the third 2-min fraction, a 1-min pulse of nicotine, nicotine plus toxin, cytisine or cytisine plus toxin was applied, followed by a 10-min wash with superfusion buffer alone. In experiments examining the reversibility of toxins, no toxin was present when the nicotine or cytisine pulse was applied after the toxin washout period. At the end of the superfusion, filters containing the synaptosomes were taken out and placed directly in vials containing 4 ml Ecolume to determine total [ 3 H]NE uptake. Radioactivity collected in each fraction was quantitated by liquid scintillation spectroscopy, with a Beckman 5801 liquid scintillation counter, tritium efficiency approximately 50%.
This article has not been copyedited and formatted. The final version may differ from this version. Data Analysis. Throughout this paper, tritium release is presumed to correspond directly to amounts of radiolabeled transmitter release, as it has been shown previously that tritium released by nAChR agonists is proportional to total radiolabeled transmitter released (Rapier et al., 1988) .
To account for experimental variations in tissue amount, release was calculated relative to the baseline. Baseline release was determined as the average of two fractions before (fractions # 2 and 3) and two fractions after (fractions #6 and 7) the peak release (fractions #4 and 5). Average baseline was subtracted from the evoked release and the resulting values divided by the baseline to yield the evoked release as a percent over baseline. The percent release above baseline in fractions 4 and 5 were then added together to yield total evoked release (or "area-under-the-curve"). Since the total [ 3 H]NE uptake among chambers within each experiment was very consistent (less than 10% deviation), it was assumed that similar amount of tissue was loaded into each chamber.
For all data, except those in figures 1B, percent release over baseline was normalized to average release by 100 µM nicotine (or cytisine in case of Fig. 9 ) alone or to release by 100 µM nicotine in wildtype mice, as indicated. The IC 50 for α-CTX BuIA inhibition was determined by non-linear regression analysis using Prism (Graphpad, San Diego, CA). All statistical analysis was performed with Prism. Toxin effects were analyzed by one-way ANOVA, followed by Dunnett's post-hoc for comparisons with nicotine control.
Results
This article has not been copyedited and formatted. The final version may differ from this version. Block of rat, human and mouse nAChRs by this toxin is rapidly reversed in subtypes that have an αx/β2 interface (t 1/2 for recovery from block < 1.5 min for all except α6β2β3
where t 1/2 ≈ 10 min); in contrast its block is very slowly reversed in nAChRs containing an αx/β4 interface (t 1/2 > 30 min) . α-CTX BuIA dose-dependently After superfusing the synaptosomes with α-CTX BuIA for 20 min, the synaptosomes were washed with toxin-free buffer. As shown in Fig. 3A , even after a 20-min wash with toxin-free buffer, nicotine-evoked [ 3 H]NE release did not recover from the level of initial toxin block. To ascertain that the lack of reversibility was a true toxin-dependent effect rather than an artifact of the experimental procedure, the reversibility of the block by α-CTX AuIB was also examined. α-CTX AuIB blocks α3β4 nAChRs more potently than α6β4 nAChRs, with IC 50 s of 0.5 ± 0.14 µM and > 5µM, respectively (5 µM toxin blocks This article has not been copyedited and formatted. The final version may differ from this version. release from 2-3 week old WT mouse hippocampal synaptosomes. However, in contrast to adult rat (where inhibition was pseudo-irreversible), the inhibition by α-CTX BuIA was partially reversed after toxin washout (Fig. 4A) , suggesting the presence of both β2
(without β4) and β4-containing nAChRs.
To further characterize the identity of the nAChR subtypes that regulate [ 3 H]NE release from postnatal WT mouse hippocampal synaptosomes, release was examined in the presence of three subtype-selective α-conotoxins: α-CTX MII (selective for α3β2, α6β2* and α6β4 nAChRs (Cartier et al., 1996; Champtiaux et al., 2002; Vailati et al., 1999) , α-CTX PIA (selective for α6β2* and α6β4 nAChRs (Dowell et al., 2003) ) and α-CTX AuIB (selective for α3β4 (Luo et al., 1998 ) > α6β4). In contrast to adult rat, where (Kulak et al., 1997; Luo et al., 1998) , 100 nM α-CTX MII almost completely blocked nicotine-evoked [ 3 H]NE release from postnatal mouse hippocampal synaptosomes (Fig. 5A ). 10 nM α-CTX PIA, a concentration that blocks α6β2* nAChRs by ~ 85% and blocks α6β4 nAChRs by ~ 20%, but only blocks α3β2 by ∼10% (Dowell et al., 2003) , inhibited nicotine-evoked [ 3 H]NE release by 80 ± 9.4% (Fig. 5A ). α-CTX AuIB, at 5 µM, blocked nicotine-evoked [ 3 H]NE release by 14 ± 3.8% (Fig. 5A ). Since the α-CTX AuIB-sensitive fraction was quantitatively similar to the α-CTX PIA-insensitive release, both toxins were co-applied This article has not been copyedited and formatted. The final version may differ from this version. to determine if the α-CTX PIA insensitive component could be eliminated by α-CTX AuIB. Co-application of 10 nM α-CTX PIA and 5 µM α-CTX AuIB did not produce a greater inhibition than that seen with 10 nM α-CTX PIA alone (Fig. 5A ).
To ascertain whether the difference in the pharmacology of nicotinic regulation of and significantly decreased in α4-/-and β3-/-mice (Fig. 6) . Interestingly, nicotineevoked [ 3 H]NE release in β4-/-pups was similar to the level in the WT (Fig. 6 ), despite the fact that the partial reversibility of α-CTX BuIA indicated the presence of the β4 subunit in a subpopulation of nAChRs that modulate [ 3 H]NE release in WT pups (see above). However, α-CTX BuIA block was fully reversed in β4-/-pups (Fig. 7B ),
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 7A) , consistent with α-CTX AuIB being inactive on β2-containing nAChRs (Luo et al., 1998) .
Nicotine-evoked [ 3 H]NE release was also pharmacologically examined in synaptosomes from mouse pups that lack either the α4 or the β3 subunit. In α4-/-pups, release was decreased by almost 80% relative to the WT (Fig. 6, 8A) , suggesting that the α4 subunit is present in a large proportion of functional nAChRs on hippocampal terminals. The residual release in these animals was completely blocked by α-CTX MII and α-CTX BuIA and blocked approximately 76% by α-CTX PIA (Fig. 8A ). In the β3-/-pups, [ 3 H]NE release was decreased by almost 90% relative to the WT. The residual release was not sensitive to any of the α-CTXs (Fig. 8B ).
We also examined whether the developmental decline in nicotine-evoked [
release observed in WT mice also occurs in β4-/-mice . Similar to WT mouse, β4-/-adult mouse displayed only 16.9 ± 10.5% release above baseline in response to 100 µM nicotine, with no additional release (16.6 ± 4%) at 300 µM nicotine .
Cytisine is an efficacious agonist at β2-containing nAChRs present on mouse noradrenergic terminals
Cytisine is a nAChR agonist formerly reported to be highly efficacious at β4-containing nAChRs (Chavez-Noriega et al., 1997; Colquhoun and Patrick, 1997; Luetje and Patrick, 1991) , but only poorly efficacious at β2-containing nAChRs (Papke and Heinemann, 1994 was reversed by 80.5 ± 3.4% after a 20-min wash with toxin-free buffer (Fig. 9A ), suggesting involvement of mostly β2-containing nAChRs. The high efficacy of cytisine at β2-containing nAChRs was further confirmed in β4-/-mice. In these mice, 100 µM cytisine was 82 ± 6% as efficacious as nicotine in stimulating [ 3 H]NE release. This release was almost completely blocked by 1 µM α-CTX BuIA and the block was fully reversed after a 20-min wash with toxin-free buffer (Fig. 9B ).
Discussion
In release decreases with age in mice. A first major pharmacological difference between the two species is that mouse nAChRs are potently blocked by α6*-selective antagonists whereas rat nAChRs are not. Second, in addition to a population of β2 and β4-containing nAChRs, there is a separate sub-population of only β2-containing nAChRs on mouse noradrenergic terminals, whereas in the rat, all nAChRs appear to contain a β4 subunit.
The results from the present study are summarized in Table 1 .
nAChRs on rat hippocampal noradrenergic terminals
Previous work identified a subpopulation of α3β4-like nAChRs in nicotine- and postnatal rats, as evidenced by the pseudo-irreversible block by α-CTX BuIA. In addition, there is an absence of nAChRs that have an α6/βx or α3/β2 subunit interface in both developmental time-points, as evidenced by the lack of block by α-CTX MII (Kulak et al., 1997; Luo et al., 1998) . The partial block by 5 µM α-CTX AuIB indicates the presence of a population of α3β4* and/or α6β4* nAChRs. However, lack of block by α-CTX MII excludes the α6β4* subtype. This is in contrast to LC nAChRs that modulate adult rat hippocampal NE release. Microinjection of α-CTX MII and α-CTX AuIB into the LC blocks hippocampal NE release by 67% and 44%, respectively. Coadministration of the two toxins does not produce a greater inhibition than α-CTX MII, suggesting presence of nAChRs with both the β2 and the β4 subunits (Fu et al., 1999) .
The greater inhibition by α-CTX MII suggests the possible presence of additional α3β2* and/or α6β2* subtype(s), without β4, that are not sensitive to block by α-CTX AuIB. The present findings, together with those of Fu et al., 1999 , indicate that systemic nicotine stimulates hippocampal NE release by targeting different subtypes of nAChRs that are present in rat LC and on rat hippocampal NE terminals.
Possible candidates for the α-CTX AuIB-resistant nAChRs on rat hippocampal noradrenergic terminals are those that contain an α4/β4 or α2/β4 interface. However, in light of the absence of α2 mRNA in both postnatal and adult LC (Lena et al., 1999; Vincler and Eisenach, 2003) , the α2β4* subtype can be excluded. The α4 subunit mRNA and protein have been detected in the rat LC (Lena et al., 1999; Vincler and This article has not been copyedited and formatted. The final version may differ from this version. Eisenach, 2003) . The β2 subunit may also be present on the terminals, but the irreversible block by α-CTX BuIA suggests that any β2-containing nAChRs also contain a β4 subunit at the other ligand-binding interface. The presence of the putative structural subunits α5 and β3 in these nAChRs is also a possibility, especially since the mRNA for both subunits have been detected in the LC (Lena et al., 1999) .
nAChRs on mouse hippocampal noradrenergic terminals
In the mouse hippocampus, much more detailed studies were able to be performed due to the availability of nAChR subunit deficient mice. In contrast to postnatal and adult rats, results from the null mutant mice indicate that all nAChRs that regulate nicotine-evoked [ 3 H]NE release contain a β2 subunit. A large proportion of these nAChRs also contain β3 and/or α4 subunits (Table 1) . In WT mice, partial reversibility of block by α-CTX BuIA indicates the presence of both β4* and β2*(without β4) nAChR subtypes. The β2 subunit, however, appears to be able to compensate for the β4 subunit in β4-/-mice, as evidenced by the lack of a decrease in the total amount of [ 3 H]NE release, lack of effect of α-CTX AuIB and, most notably, the complete reversibility of α-CTX BuIA inhibition.
In WT mice, block of [ 3 H]NE release by the α6βx/α3β2-selective α-CTX MII and the α6βx selective α-CTX PIA indicates that most, if not all, receptors also contain an α6 subunit. The lack of co-additivity of inhibition by 10 nM α-CTX PIA and 5 µM α-CTX AuIB suggests a common site of action, possibly the α6β4*, rather than an α3β4*, subtype. However, the presence of a small population of α6(α3)β4* subtype that is sensitive to block by both α-CTX AuIB and α-CTX PIA can not be ruled out. This is in This article has not been copyedited and formatted. The final version may differ from this version. (Luo et al., 1998) .
To further investigate the pharmacology of nAChRs on mouse noradrenergic terminals, cytisine, a ligand formerly believed to only activate β4-containing nAChRs with high efficacy (Chavez-Noriega et al., 1997; Colquhoun and Patrick, 1997; Luetje and Patrick, 1991) was used. More recent studies, however, have shown that cytisine binds to α-CTX MII sensitive sites, although with low affinity (Whiteaker et al., 2000) .
Additionally, one study has demonstrated that cytisine is as efficacious as nicotine and acetylcholine in activating α-CTX MII-sensitive nAChRs that modulate [ 3 H]DA release from mouse striatal synaptosomes (Salminen et al., 2004) . Similar to the latter study, in the present study cytisine was nearly as efficacious as nicotine in stimulating has recently been shown that the deletion of the β3 subunit decreases the number of α6-containing nAChRs on mouse DAergic terminals (Gotti et al., 2005) , indicating that α6
and β3 subunits co-participate in formation of native nAChRs.
Additional implications
NE is a neurotransmitter that is important for attentiveness, working memory and learning. Compounds that enhance memory also increase the release of NE within the hippocampus (Lee et al., 1993; Lee and Ma, 1995) . The cognitive-enhancing properties of nicotine may, in part, be mediated by the release of NE within the hippocampus SIB-1553A, a nicotinic receptor ligand with selectivity for β4-containing nAChRs, improves attention and working memory in both rats and mice (Bontempi et al., 2003; Bontempi et al., 2001; Terry et al., 2002) . SIB-1553A's beneficial effects on working memory/attention may, in part, be mediated by release of ACh (Bontempi et al., 2001; Rao et al., 2003b) , and/or NE within the hippocampus (Rao et al., 2003a) . The results of the present study, which indicate the presence of the β4 subunit in nAChRs that modulate This article has not been copyedited and formatted. The final version may differ from this version. Values are mean ± SEM from three experiments.
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